2019−2020
К другим новостям
![Meta-analysis for the value of colchicine for the therapy of pericarditis and of postpericardiotomy syndrome]()
24.06.2020
![The effect of low-dose colchicine in patients with stable coronary artery disease: The LoDoCo2 trial rationale, design, and baseline characteristics]()
24.06.2020
![Clinical efficacy and safety of dotinurad, a novel selective urate reabsorption inhibitor, in Japanese hyperuricemic patients with or without gout: randomized, multicenter, double-blind, placebo-controlled, parallel-group, confirmatory phase 2 study]()
24.06.2020
![Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction]()
24.06.2020
24.06.2020
Meta-analysis for the value of colchicine for the therapy of pericarditis and of postpericardiotomy syndrome
BACKGROUND: Colchicine has been used as anti-inflammatory agent in pericardial effusion (PE). We sought to perform a meta-analysis of randomized trials assessing the efficacy and...
Далее
24.06.2020
The effect of low-dose colchicine in patients with stable coronary artery disease: The LoDoCo2 trial rationale, design, and baseline characteristics
Because patients with stable coronary artery disease are at continued risk of major atherosclerotic events despite effective secondary prevention strategies, there is a need...
Далее
24.06.2020
Clinical efficacy and safety of dotinurad, a novel selective urate reabsorption inhibitor, in Japanese hyperuricemic patients with or without gout: randomized, multicenter, double-blind, placebo-controlled, parallel-group, confirmatory phase 2 study
BACKGROUND: Dotinurad, a novel selective urate reabsorption inhibitor (SURI), reduces serum uric acid levels by selectively inhibiting urate transporter 1 (URAT1) for the treatment...
Далее
24.06.2020
Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction
BACKGROUND: Experimental and clinical evidence support the role of inflammation in atherosclerosis and its complications. Colchicine is an orally administered, potent antiinflammatory...
Далее
